Page last updated: 2024-09-03

2-(2,3-dicarboxycyclopropyl)glycine and am 251

2-(2,3-dicarboxycyclopropyl)glycine has been researched along with am 251 in 1 studies

Compound Research Comparison

Studies
(2-(2,3-dicarboxycyclopropyl)glycine)
Trials
(2-(2,3-dicarboxycyclopropyl)glycine)
Recent Studies (post-2010)
(2-(2,3-dicarboxycyclopropyl)glycine)
Studies
(am 251)
Trials
(am 251)
Recent Studies (post-2010) (am 251)
1660279481507

Protein Interaction Comparison

ProteinTaxonomy2-(2,3-dicarboxycyclopropyl)glycine (IC50)am 251 (IC50)
Cannabinoid receptor 1Homo sapiens (human)0.0892

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Konishi, S; Rusakov, D; Saitow, F; Satake, S1

Other Studies

1 other study(ies) available for 2-(2,3-dicarboxycyclopropyl)glycine and am 251

ArticleYear
AMPA receptor-mediated presynaptic inhibition at cerebellar GABAergic synapses: a characterization of molecular mechanisms.
    The European journal of neuroscience, 2004, Volume: 19, Issue:9

    Topics: Action Potentials; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzothiadiazines; Benzoxazines; Calcium; Calcium Channel Blockers; Cerebellum; Chelating Agents; Colforsin; Cyclopropanes; Drug Interactions; Egtazic Acid; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; GABA Antagonists; gamma-Aminobutyric Acid; Glycine; In Vitro Techniques; Morpholines; Naphthalenes; Neural Inhibition; Neurons; Piperidines; Presynaptic Terminals; Pyrazoles; Rats; Rats, Wistar; Receptors, AMPA; Ryanodine; Synapses; Triazines; Triazoles

2004